| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/JM0605740 |
| P8608 | Fatcat ID | release_nofnt4pywndttharnvbznvfcu4 |
| P698 | PubMed publication ID | 17064068 |
| P5875 | ResearchGate publication ID | 6732197 |
| P50 | author | Peter M. Fischer | Q39590015 |
| Vladimír Kryštof | Q40148010 | ||
| Miroslav Strnad | Q57633656 | ||
| Marián Hajdúch | Q73099106 | ||
| P2093 | author name string | George Kontopidis | |
| Jakub Rolcík | |||
| Walter F de Azevedo | |||
| Petr Dzubák | |||
| Josef Srovnal | |||
| Iveta Frysová | |||
| Jan Slouka | |||
| Ales Látr | |||
| Martin Orság | |||
| Martina Paprskárová | |||
| Petr Cankar | |||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6500-6509 | |
| P577 | publication date | 2006-11-01 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | 4-arylazo-3,5-diamino-1H-pyrazole CDK inhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects | |
| P478 | volume | 49 |
| Q92556942 | A Dual Inhibitor of Cdc7/Cdk9 Potently Suppresses T Cell Activation |
| Q39713734 | A cancer-derived mutation in the PSTAIRE helix of cyclin-dependent kinase 2 alters the stability of cyclin binding |
| Q39679283 | A combinatorial in silico and cellular approach to identify a new class of compounds that target VEGFR2 receptor tyrosine kinase activity and angiogenesis. |
| Q85520625 | A facile synthesis of new monoazo disperse dyes derived from 4-hydroxyphenylazopyrazole-5-amines: evaluation of microwave assisted dyeing behavior |
| Q35243650 | A molecular mechanics approach to modeling protein-ligand interactions: relative binding affinities in congeneric series |
| Q36667837 | Adenovirus L-E1A activates transcription through mediator complex-dependent recruitment of the super elongation complex |
| Q33709855 | Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma |
| Q31160552 | Arylazopyrazole AAP1742 inhibits CDKs and induces apoptosis in multiple myeloma cells via Mcl-1 downregulation. |
| Q39164217 | CDK9-dependent transcriptional elongation in the innate interferon-stimulated gene response to respiratory syncytial virus infection in airway epithelial cells |
| Q49536215 | Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. |
| Q35903324 | Chemically modified peptides targeting the PDZ domain of GIPC as a therapeutic approach for cancer |
| Q27675539 | Comparative Structural and Functional Studies of 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidine-5-carbonitrile CDK9 Inhibitors Suggest the Basis for Isotype Selectivity |
| Q38970003 | Coordinate activities of BRD4 and CDK9 in the transcriptional elongation complex are required for TGFβ-induced Nox4 expression and myofibroblast transdifferentiation. |
| Q36015334 | Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy |
| Q37536656 | Cyclin dependent kinase-9 mediated transcriptional de-regulation of cMYC as a critical determinant of endocrine-therapy resistance in breast cancers |
| Q37697797 | Cyclin-dependent kinase inhibitors: a survey of recent patent literature |
| Q38859827 | Discovery of nitroaryl urea derivatives with antiproliferative properties |
| Q59011499 | Efficient and Convenient Route for the Synthesis of Some New Antipyrinyl Monoazo Dyes: Application to Polyester Fibers and Biological Evaluation |
| Q59055934 | Fluorine Substituted 1,2,4-Triazinones as Potential Anti-HIV-1 and CDK2 Inhibitors |
| Q41457054 | Identification of novel inhibitors against Cyclin Dependent Kinase 9/Cyclin T1 complex as: Anti cancer agent |
| Q48253446 | Modification of Boc-Protected CAN508 via Acylation and Suzuki-Miyaura Coupling. |
| Q47787864 | Molecular modelling on small molecular CDK2 inhibitors: an integrated approach using a combination of molecular docking, 3D-QSAR and pharmacophore modelling |
| Q39768989 | Novel imatinib derivatives with altered specificity between Bcr-Abl and FMS, KIT, and PDGF receptors |
| Q55070378 | Novel thiosemicarbazides induced apoptosis in human MCF-7 breast cancer cells via JNK signaling. |
| Q38696353 | Overview of CDK9 as a target in cancer research. |
| Q38008733 | Perspective of cyclin-dependent kinase 9 (CDK9) as a drug target. |
| Q38253652 | Pyrazoles as potential anti-angiogenesis agents: a contemporary overview |
| Q37855864 | Recent advances on structure-informed drug discovery of cyclin-dependent kinase-2 inhibitors |
| Q38806786 | Recent progress of cyclin-dependent kinase inhibitors as potential anticancer agents |
| Q35531231 | RelA Ser276 phosphorylation-coupled Lys310 acetylation controls transcriptional elongation of inflammatory cytokines in respiratory syncytial virus infection |
| Q39551472 | Structural Bioinformatics Approach of Cyclin-Dependent Kinases 1 and 3 Complexed with Inhibitors |
| Q49611613 | Synthesis of 4-substituted pyrazole-3,5-diamines via Suzuki-Miyaura coupling and iron-catalyzed reduction. |
| Q64077062 | Synthesis, In Vitro Antimicrobial and Cytotoxic Activities of Some New Pyrazolo[1,5-]pyrimidine Derivatives |
| Q93026463 | Synthesis, biological evaluation, and molecular modeling of nitrile-containing compounds: Exploring multiple activities as anti-Alzheimer agents |
| Q36133996 | Systematic Determination of Human Cyclin Dependent Kinase (CDK)-9 Interactome Identifies Novel Functions in RNA Splicing Mediated by the DEAD Box (DDX)-5/17 RNA Helicases |
| Q27676963 | The CDK9 C-helix Exhibits Conformational Plasticity That May Explain the Selectivity of CAN508 |
Search more.